HCW Biologics Inc. (HCWB): Cash & Equivalents
$1.95M
As of 2025-12-31
$741.3K
As of 2026-06-30
-55.6%
3-year compound annual growth
-25.4%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.95M | -58.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $4.67M | +30.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $3.60M | -83.9% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $22.33M | +90.3% | 2024-05-15, Balance as of period end |
| 2021-12-31 | $11.73M | +38.7% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $8.46M | n/a | 2022-03-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.95M | -58.2% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $1.71M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $43.76M | +18.5% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $58.7K | -9.5% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $60.18M | -43.0% |
Compare HCWB, LNAI, AVTX, CNTB side by side · Screen every company in Pharmaceutical Preparations ↗